The purpose of this study is to evaluate whether liposomal bupivacaine is superior to normal bupivacaine in terms of providing better pain control postoperatively after total knee arthroplasty.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
266 mg or 20 ml Liposomal Bupivacaine injectable solution
0.5% (5mg/mL) 20 mL single dose SOC anesthetic Ropivacaine.
Opioid Use
Opioid use after SoC TKA surgery will be evaluated as morphine milligram equivalents
Time frame: Up to 2 weeks
Distance Ambulated with physical therapist
Average daily distance ambulated using the 6 minute walk test
Time frame: Up to 5 days
Length of hospitalization
Number of days of hospitalization after elective admission for TKA surgery
Time frame: Up to 5 days
Incidence of events of PONV
Incidence of post-operative nausea and vomiting (PONV) will be reported throughout the duration of hospitalization
Time frame: Up to 5 days
Number of participants requiring narcotic prescriptions
The number of participants that require further narcotic prescriptions will be reported
Time frame: 2 weeks
Incidence of urinary retention from narcotic use
Incidence of urinary retention from narcotic use will be measured via the need for urethral catheterization.
Time frame: 2 Weeks
Post-Operative Pain Score
Post-Operative Pain will be measured via a self-reported Visual Analog Scale (VAS) score. The VAS Pain score ranges from 1-10 with 1 being free of pain and 10 being the most pain.
Time frame: Up to 5 days
Patient Satisfaction as per the Knee Society Score
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
The Knee society score has a total score ranging from 100-0. Scores between 100 and 85 points are considered excellent results, scores between 84 and 70 points are considered good results. Scores between 69 and 60 points are considered fair, and scores less than 60 are considered poor results
Time frame: Up to Week 6